# Deferoxamine mesylate

NDC: 68083-172
Generic name: Deferoxamine mesylate
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20171009

FDA application: ANDA207384

## Active ingredients

- DEFEROXAMINE MESYLATE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-172"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-172
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=598fba68-f46e-4b6e-894c-63c2940b2063